KRAS and lung adenocarcinoma: Corrigendum: <i>TP53</i> co-mutations in advanced lung adenocarcinoma: comparative bioinformatic analyses suggest ambivalent character on overall survival alongside <i>KRAS</i>, <i>STK11</i> and <i>KEAP1</i> mutations.